ASAM Pocket Guidelines and Patient Guide

Alcohol Withdrawal Management

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1254278

Contents of this Issue

Navigation

Page 33 of 45

34 Treatment D. Patients with Medical Conditions Î Recommendation VII.21: For patients with medical comorbidities, modify the medication and/or protocol used for treating alcohol withdrawal syndrome as necessary in consultation with other specialists. Î Recommendation VII.22: For patients with medical conditions that prevent the use of oral medication, provide intravenous or intramuscular medications as necessary. Î Recommendation VII.23: Aggressive withdrawal treatment is indicated for patients with cardiovascular disorders due to risk of harm associated with autonomic hyperactivity. Î Recommendation VII.24: For patients with a medical condition associated with impaired hepatic function, adjust medication dose or use medications with less dependence on hepatic metabolism. E. Patients who Take Opioids Î Recommendation VII.25: Patients who are on chronic opioid medication (opioid agonist therapy for opioid use disorder or pain) should be monitored closely when benzodiazepines are prescribed, due to the increased risk of respiratory depression. Similarly, patients taking sedative-hypnotic medications exhibit tolerance to benzodiazepines and should be monitored closely for appropriate dose. Î Recommendation VII.26: For patients with concomitant alcohol withdrawal and opioid use disorder, stabilize opioid use disorder (e.g., with methadone or buprenorphine) concomitantly with treating alcohol withdrawal. F. Patients who are Pregnant (1) Level of care and monitoring Î Recommendation VII.27: Inpatient treatment should be considered for all pregnant patients with alcohol use disorder who require withdrawal management. Inpatient treatment should be offered to pregnant patients with at least moderate alcohol withdrawal (i.e., CIWA-Ar scores ≥10). Î Recommendation VII.28: The CIWA-Ar is an appropriate symptom assessment scale to use with pregnant patients. Clinicians should consider signs and symptoms such as nausea, headache, anxiety, and insomnia to be connected to alcohol withdrawal rather than pregnancy that will abate once the alcohol withdrawal has been effectively treated. Î Recommendation VII.29: During withdrawal management, consult with an obstetrician.

Articles in this issue

view archives of ASAM Pocket Guidelines and Patient Guide - Alcohol Withdrawal Management